Penserra Capital Management LLC purchased a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 48,482 shares of the construction company's stock, valued at approximately $1,342,000. Penserra Capital Management LLC owned about 0.06% of Aspen Aerogels at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of ASPN. Algert Global LLC raised its holdings in shares of Aspen Aerogels by 60.2% during the 3rd quarter. Algert Global LLC now owns 127,764 shares of the construction company's stock valued at $3,538,000 after buying an additional 48,007 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Aspen Aerogels by 204.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 509,430 shares of the construction company's stock valued at $14,106,000 after acquiring an additional 342,253 shares during the last quarter. Intech Investment Management LLC purchased a new position in shares of Aspen Aerogels during the third quarter worth approximately $497,000. Quest Partners LLC lifted its holdings in shares of Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock worth $205,000 after acquiring an additional 5,361 shares during the last quarter. Finally, Sargent Investment Group LLC boosted its stake in shares of Aspen Aerogels by 1.8% in the 3rd quarter. Sargent Investment Group LLC now owns 323,369 shares of the construction company's stock valued at $8,954,000 after purchasing an additional 5,830 shares in the last quarter. Institutional investors own 97.64% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on ASPN. Barclays decreased their target price on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research report on Tuesday, November 12th. HC Wainwright restated a "buy" rating and set a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm cut their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a report on Friday, November 8th. Benchmark reissued a "buy" rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $28.70.
View Our Latest Research Report on Aspen Aerogels
Insider Transactions at Aspen Aerogels
In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 4.30% of the company's stock.
Aspen Aerogels Stock Up 1.0 %
ASPN traded up $0.14 during midday trading on Wednesday, reaching $14.48. The company's stock had a trading volume of 1,320,040 shares, compared to its average volume of 1,633,263. Aspen Aerogels, Inc. has a 1 year low of $10.31 and a 1 year high of $33.15. The stock's 50-day moving average is $20.48 and its 200-day moving average is $24.08. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 1,449.45 and a beta of 2.21. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27.
Aspen Aerogels Company Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.